GlaxoSmithKline PLC Director/PDMR Shareholding (4500C)
January 19 2018 - 12:17PM
UK Regulatory
TIDMGSK
RNS Number : 4500C
GlaxoSmithKline PLC
19 January 2018
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated
with them ('PCA')
=== ===========================================================
a) Name Mr N Hirons
=== ====================== ===================================
b) Position/status SVP, Global Ethics & Compliance
=== ====================== ===================================
c) Initial notification/ Initial notification
amendment
=== ====================== ===================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== ===========================================================
a) Name GlaxoSmithKline plc
=== ====================== ===================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== ===================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== ===========================================================
a) Description GlaxoSmithKline plc American
of the financial Depositary Shares ('ADSs')
instrument ISIN: US37733W1053
=== ====================== ===================================
b) Nature of Acquisition of ADSs following
the transaction the re-investment of dividends
paid to shareholders on 11 January
2018.
=== ====================== ===================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- ----------
$38.0676 19.625
--------- ----------
=== ====================== ===================================
d) Aggregated n/a (single transaction)
information
Aggregated
volume Price
=== ====================== ===================================
e) Date of the 2018-01-18
transaction
=== ====================== ===================================
f) Place of the New York Stock Exchange (XNYS)
transaction
=== ====================== ===================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== ===========================================================
a) Name Mr B McNamara
=== ====================== ===================================
b) Position/status CEO, Consumer Healthcare
=== ====================== ===================================
c) Initial notification/ Initial notification
amendment
=== ====================== ===================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== ===========================================================
a) Name GlaxoSmithKline plc
=== ====================== ===================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== ===================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== ===========================================================
a) Description American Depositary Shares ('ADSs')
of the financial ISIN: US37733W1053
instrument
=== ====================== ===================================
b) Nature of Acquisition of ADSs following
the transaction the re-investment of dividends
paid to shareholders on 11 January
2018.
=== ====================== ===================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- ----------
$38.0676 232.515
--------- ----------
=== ====================== ===================================
d) Aggregated n/a (single transaction)
information
Aggregated
volume Price
=== ====================== ===================================
e) Date of the 2018-01-18
transaction
=== ====================== ===================================
f) Place of the New York Stock Exchange (XNYS)
transaction
=== ====================== ===================================
1. Details of PDMR/person closely associated
with them ('PCA')
=== ===========================================================
a) Name Mr D E Troy
=== ====================== ===================================
b) Position/status SVP & General Counsel
=== ====================== ===================================
c) Initial notification/ Initial notification
amendment
=== ====================== ===================================
2. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
=== ===========================================================
a) Name GlaxoSmithKline plc
=== ====================== ===================================
b) LEI 5493000HZTVUYLO1D793
=== ====================== ===================================
3. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transaction(s)
has been conducted
=== ===========================================================
a) Description American Depositary Shares ('ADSs')
of the financial ISIN: US37733W1053
instrument
=== ====================== ===================================
b) Nature of Acquisition of ADSs following
the transaction the re-investment of dividends
paid to shareholders on 11 January
2018.
=== ====================== ===================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- ----------
$38.0676 1826.446
--------- ----------
=== ====================== ===================================
d) Aggregated n/a (single transaction)
information
Aggregated
volume Price
=== ====================== ===================================
e) Date of the 2018-01-18
transaction
=== ====================== ===================================
f) Place of the New York Stock Exchange (XNYS)
transaction
=== ====================== ===================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHDKLFFVFFFBBZ
(END) Dow Jones Newswires
January 19, 2018 12:17 ET (17:17 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024
